1) histone acetylation/deacetylation
组蛋白乙酰化/去乙酰化
3) histone acetyltransferase (HAT)/histone deacetylase (HDACs)
组蛋白乙酰化酶/组蛋白去乙酰化酶
4) histone deacetylases
组蛋白去乙酰化酶
1.
Synthesis and activity study of a new series of histone deacetylases(HDACs) inhibitors of N-hydroxycinnamamide derivatives;
一组新的N-羟基肉桂酰胺类组蛋白去乙酰化酶抑制剂的合成和初步活性研究
2.
Histone acetyltransferases(HAT) and histone deacetylases(HDACs) as the corresponding enzymes regulate the change of histones in two antagonist forms,acetylated or deacetylated.
组蛋白乙酰转移酶(HAT)和组蛋白去乙酰化酶(HDAC)调节组蛋白乙酰化程度,HDAC在基因表达和染色体形成等方面起着重要的调节作用。
3.
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are emerging as important components of protein complexes that affect the dynamics of chromatin folding during gene transcription.
组蛋白乙酰转移酶(histone acetyltransferases, HATs)和组蛋白去乙酰化酶(histone deacetylase, HDACs)可以通过调节组蛋白或转录因子的乙酰化状态来调节基因的活化或沉默。
5) Histone deacetylase
组蛋白去乙酰化酶
1.
Differentiation of PLZF-RARα-positive U937 leukemic cells induced by histone deacetylase inhibitor trichostatin A in combination with all-trans retinoic acid;
组蛋白去乙酰化酶抑制剂曲古菌素A联合全反式维甲酸诱导PLZF-RARα阳性U937细胞分化
2.
Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism
组蛋白去乙酰化酶抑制剂协同紫杉醇对人肺癌细胞株抑制作用及机制
3.
Relationship Between Systemic Inflammation and Activity of Histone Deacetylase in Peripheral Blood Mononuclear Cells from COPD Patients
慢性阻塞性肺病外周血单个核细胞中的组蛋白去乙酰化酶活性与全身炎症的关系
6) histone deacetyase 4
组蛋白去乙酰化酶4
1.
Expression of histone deacetyase 4 in human liver carcinoma cell line Bel-7402 and its significance;
组蛋白去乙酰化酶4在人肝癌细胞Bel-7402中的表达及其意义
补充资料：乙酰化物
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条